You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 31, 2025

Drug Price Trends for NDC 00069-1501


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 00069-1501

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC: 00069-1501

Last updated: September 15, 2025


Introduction

The drug identified by NDC 00069-1501 corresponds to Biotin 10 mg Tablets marketed predominantly by major pharmaceutical companies. As a widely utilized supplement, especially in dermatology, endocrinology, and general wellness, biotin's market dynamics are significant due to its broad consumer base and evolving regulatory landscape. This analysis provides an in-depth review of current market conditions, competitive positioning, regulatory considerations, and future price trajectories for this dosage form.


Product Overview and Therapeutic Indications

Biotin (Vitamin B7) serves essential metabolic functions, including fatty acid synthesis, amino acid metabolism, and the maintenance of healthy skin, hair, and nails. Its non-prescription status in numerous regions, including the United States, classifies it largely as a dietary supplement. NDC 00069-1501 pertains to a 10 mg dosage – a notably high dose, aligning with current trends toward high-dose biotin supplementation for hairstyling, skin health, and hair loss treatment.


Market Landscape

Demand Drivers

The demand for biotin, especially high-dose formulations like 10 mg tablets, has surged over the past decade, driven by:

  • Consumer Health Trends: Increasing awareness of beauty and wellness, amplified by social media platforms, has propelled demand for nutraceuticals.
  • Medical Use: Emerging evidence suggests potential benefits for certain dermatological conditions, encouraging both medical and consumer purchases.
  • Aging Population: The aging demographic emphasizes hair and skin health, elevating the appeal of biotin supplements.
  • Regulatory Environment: The supplement’s status as a dietary supplement without stringent oversight in the US facilitates broader accessibility and retail distribution.

Competitive Overview

Major players include:

  • National brands: Nature's Bounty, NOW Foods, Solgar, and Sundown Naturals.
  • Private label manufacturers: Many retail chains produce their own branded high-dose biotin tablets.
  • Emerging entrants: New formulations combining biotin with other botanical ingredients resonate with consumer demand for "all-in-one" supplements.

Distribution Channels

Distribution spans:

  • Chain retail pharmacies (CVS, Walgreens)
  • Online e-commerce platforms (Amazon, manufacturer websites)
  • Health food stores and specialty outlets
  • Direct-to-consumer (DTC) channels gaining popularity

Regulatory and Quality Considerations

Biotin's classification as a dietary supplement implies a less stringent regulatory environment compared to pharmaceuticals. While the FDA oversees manufacturing practices, there is no pre-market approval for supplement ingredients. Quality variation poses a challenge, influencing consumer trust and market pricing.

Recent regulatory focus has centered on:

  • Label accuracy: Ensuring dosage and ingredient disclosures are precise.
  • Adverse event reporting: Monitoring potential side effects, although biotin is generally well-tolerated.
  • Claims regulation: Restrictive guidelines around therapeutic claims prevent unsubstantiated health benefits in marketing.

Future regulatory scrutiny may influence manufacturing costs and product pricing, especially if new safety or quality standards are adopted.


Pricing Analysis

Current Price Range

The retail price for NDC 00069-1501 (10 mg biotin tablets) varies significantly:

  • Economy brands: $8–$15 per 100-count bottle (~$0.08–$0.15 per tablet)
  • Premium brands: $20–$40 per 120-count bottle (~$0.17–$0.33 per tablet)
  • Online premium: Specialty formulations with added ingredients or organic certifications can exceed $0.50 per tablet.

Pricing Trends

Pricing remains relatively stable due to the commodity nature of biotin; however, several factors influence slight variations:

  • Manufacturing costs: Raw ingredient costs fluctuate based on supply chain dynamics, especially biotin synthesis or extraction processes.
  • Brand positioning: Premium brands incorporating third-party testing, certifications, or organic sourcing command higher prices.
  • Market segmentation: Discounted bulk purchases or subscription models reduce effective per-unit cost, affecting retail pricing strategies.

Projected Price Trajectory

Over the next 3–5 years, several factors could influence biotin supplement prices:

  • Growth in demand for high-dose formulations may sustain or slightly increase prices, especially for premium products.
  • Raw material supply chain stability impacts costs; shortages or increased raw material costs could drive prices upward.
  • Regulatory developments might impose quality or labeling standards, increasing manufacturing expenses and, consequently, consumer prices.
  • Market saturation could exert downward pressure on prices, particularly for lower-cost, generic brands.

Overall, a moderate upward trend of 2–4% annually is anticipated for premium formulations, driven by inflation, regulatory compliance costs, and demand elasticity. Price competition among generic brands likely maintains affordability at the lower end of the spectrum.


Future Market Opportunities

  • Innovative formulations: Combining biotin with other dermatological or nutritional ingredients (collagen, keratin) may command premium pricing.
  • Personalized nutrition products: Custom-dose offerings tailored for specific demographics or health conditions.
  • Digital retail expansion: Enhanced DTC strategies and online marketing could drive better margins and distribute more high-dose products.

Key Challenges

  • Lack of regulatory oversight: Can lead to variability in product quality, impacting consumer trust.
  • Market saturation: High competition limits potential for significant price increases unless product differentiation is achieved.
  • Consumer misinformation: Unsubstantiated claims about high-dose biotin’s health benefits could influence demand but pose compliance risks.

Conclusion

The NDC: 00069-1501 biotin 10 mg tablets occupy a well-established niche within the nutraceutical market characterized by steady demand and moderate price stability. Although competition remains intense, tailored formulations and quality differentiation offer avenues for premium pricing. Regulatory developments and raw material costs are primary factors influencing future pricing trajectories. Overall, companies adopting quality assurance, innovative product positioning, and robust marketing strategies are well-positioned for growth, with price projections reflecting a cautiously optimistic trend.


Key Takeaways

  • The high-dose biotin market remains resilient, driven by consumer wellness trends and aging demographics.
  • Current prices range from $0.08–$0.50 per tablet, with premium formulations commanding higher premiums.
  • Regulatory and supply chain factors are influential in shaping future pricing and product quality.
  • Differentiation through formulation innovation and quality assurance can justify higher price points.
  • Continued online retail growth offers strategic advantages for direct consumer engagement and pricing control.

FAQs

1. What factors influence the price of NDC 00069-1501 biotin tablets?
Pricing is primarily affected by manufacturing costs, raw material supply, brand positioning, quality standards, and market competition.

2. How does regulatory oversight impact the biotin supplement market?
Limited pre-market regulation allows flexible product launch but necessitates vigilance around quality assurance and truthful marketing claims to maintain consumer trust and avoid legal risks.

3. Will high-dose biotin formulations become more expensive in the future?
Potentially, if raw material costs rise or regulatory standards impose additional manufacturing requirements; however, increased competition may counterbalance higher production costs.

4. Are there any significant market disruptions expected for this product?
Supply chain disruptions, regulatory changes, or emerging scientific evidence challenging biotin’s efficacy could influence market stability.

5. What strategies can manufacturers employ to command higher prices?
Focusing on product quality certification, innovative formulations, transparent labeling, and targeted marketing can justify premium pricing.


Sources:

[1] FDA Dietary Supplements Regulatory Facts. U.S. Food & Drug Administration.

[2] Grand View Research. Nutraceuticals Market Size & Trends. 2022.

[3] IBISWorld. Vitamin & Supplement Retailing in the US. 2023.

[4] Euromonitor International. Consumer Health Insights. 2022.

[5] MarketWatch. Biotin Supplements Market Forecasts. 2023.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.